Lurasidone, known commercially as Latuda, is a class antipsychotic drug, used to treat symptoms of schizophrenia and depression caused by bipolar disorder.
This drug was recently approved by Anvisa for sale in pharmacies in Brazil, in tablets of 20 mg, 40 mg and 80 mg, in boxes of 7, 14, 30 or 60 tablets, and can be found or ordered in the main pharmacies. Antipsychotic, Lurasidone is in the category of controlled drugs and is sold only with a special prescription in two copies.
Lurasidone is used to treat
This drug is an antipsychotic, which acts as a selective blocking agent for the effects of dopamine and monoamine, which are brain neurotransmitters, important for improving symptoms.
However, it works with some improvements compared to older antipsychotics, such as minor changes in metabolism, which have less effect on weight gain and changes in the body’s fat and glucose profile.
Lurasidone tablets should be taken orally, once daily, with meals, and are recommended to be taken at the same time every day. In addition, the tablets should be swallowed whole, to avoid their bitter taste.
Some of the most common side effects of lurasidone are drowsiness, restlessness, dizziness, involuntary movements, insomnia, restlessness, anxiety or weight gain.
Other possible effects include seizures, decreased appetite, lethargy, blurred vision, tachycardia, changes in blood pressure, dizziness or changes in blood count, for example.
Lurasidone is indicated by contrast in the presence of
Due to the interaction with the effect of these medicines, the list of medicines used should always be communicated to the accompanying doctor.
Lurasidone should be used with caution in people with moderate to severe kidney disease or liver disease, Parkinson’s disease, movement disorders, cardiovascular disease or other neurological diseases. In addition, this medicine has not been tested in elderly patients with dementia or in children, so its use should be avoided in these cases.